The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved...
The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved...
SAN DIEGO, July 29, 2025 /PRNewswire/ -- QuidelOrtho earned three awards and top rankings in the 2025 IMV ServiceTrak™ Awards, presented at the Association...
Key Takeaways
At AAIC 2025, the Alzheimer's Association released the first in a series of clinical practice guidelines for the diagnosis, treatment and care of...
ARLINGTON, Va., July 29, 2025 /PRNewswire/ -- A new report from Kalorama Information reveals that the global point-of-care (POC) diagnostics market surged past $36 billion...
Building on its initial announcement, Info-Tech Research Group, a global IT research and advisory firm, has announced the first round of featured speakers for...
Building on its initial announcement, Info-Tech Research Group, a global IT research and advisory firm, has announced the first round of featured speakers for...
Building on its initial announcement, Info-Tech Research Group, a global IT research and advisory firm, has announced the first round of featured speakers for...
In this free webinar, learn how advanced autoimmune testing supports diagnostic clarity in early or ambiguous clinical presentations. The featured speakers will review case-based evidence...
Cell Biology Researcher Mark Terasaki's $25 Million Unrestricted Gift Will Support Operations and Infrastructure
WOODS HOLE, Mass., July 28, 2025 /PRNewswire/ -- The Marine Biological Laboratory...
"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative...
"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative...